| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |